months after lead exposure was dfKontlnued. l}, 6] We sugested that elevattcri In blaod pressure we related to an lll(re•e In an endotheltal-deriwd wscanstr1ttor, endothel'1·3, an tlcrease '1 the Ha·K-ATPase lnhlbttor~tdlfnl hypertenslon-assoctated protetl, and •decrease '1 cyclic auancslne rnonoph01Phate as a second messenter for the vasodilatar ccmpcund, EDRF, which h• been identified as HO. [7] [8] [9] Previous 9'1wstiptcn demCll'lstrated beth increased and decreased plasma rem acttvttles In lead~ased rats, (10, 11 ] with decreased lldMty s"-n fn nits that -re mmt comparable to the present study (100 ppm lead for 6 months). [10] The purpcses of the present study-re (1) to '1wsttpte the effects of lead expcsure on pl•ma conc:entrat.fon and urinary excretfon of NO, plasma aincentmlons ot ET·1 and ET·3, and urfnary excretion of these hcnnones; (2) to mesu1ate the effects ot lead m pl•ma and kidney MDA·DA, a reflection ot l.,ld peradde fonnatbl (lll'ld thus, ROS); and (3) to detemme whether lead ecpcsure affects NO production by tldudn1 chan,es In NOS acttvtty or protefn mass.
Methods

Animals
Fran the aee of 2 months, male Spraeue·Dlwlev rats (purchased fran Charles R~r. Inc, Wltm9'1ct«i, Mass) ~9'112001 were fed a standard rodent Purina labonltoty chM (ccntafnln1 11 cllcllm) and were also pen 0.011 lead acetate (100 ppm) t'I thri' drTllm'll water for 3 months. The ~rtnental anfmals had aee· matched CU'ltrcls. Six animals each were '1cluded In experimental and control 1roups. Rats were -tshed before entema fnto he study and also at the the of death.
Measurement of Blood ~re
Conscbls nits -re placed ti a restl'Dler and Ill.lowed to rest fnslde the ate for 15 minutes before blood pressure measurements. Rllt tals were placed fnslde a bill cuff, and the cuff was Inflated and released a few times to al'-the anfmal to be condttloned to the procedure. Mean blood pressure lllllues (four conmcutM! readfnp)
were taken by a rat tall blCIOd pressure mmltar attached to a student csdllQlraph (Harvard Apparatus Limited) 1nd awraaed for presentation. Th1s apparatus fS caplble ot recordtll beth mean blood pressure and systcltc: blCIOd pressure.
Collection of Blood and Urine
One day before k11Ung. rats were fndtvtclually placed ti metabolic caaes dur1n1 the day, and 24-hour ur1ne samples were collected fn plastic tubes placed on tee.
Urine samples were centrifuged and frozen at ·80 [delJ'ee sien] Celsa.is for determ9'1atiCll'I of cGMP, HO, creatil9'1e, and ET-1 and Er·l concentrations. On the day of klli'l1, rats were anesthetized with methmtyflurane nd thefr blood was rerncJYed throulh the heart with ., Ice-cold syringe. NI llliquut (1 ml) ot whole blood -stared llt 4 (degree sllln) Celsfus for detenntlallon of blood lead. Plasma was separated fran the red blood cells by centr1fult'l8 the blood at 3000 rpm for 15 m'1utes at 4 [dearee stfpl] Celsius. Pl•ma allquou (1 ml) were stored at ·80 [degree sign] Celst.is for determtlatfon of cGMP, HO, creat'1'1e, M~·nA, 111d ET-1 Sid ET-3 lewls.
Collec:tlon of Tissues
After re--1 of blocd, kidneys and brains were elldlecl quickly and placed cin tee. Kfdney cortex, brafn cortex, and cerebellum -re sepanted and placed Into lfqufd nttrc11en. All tissues were stclred at -80 [ 
Measurements of Urine and Plasma Nitrite and Nitrate (NO (J)"'N03)
The concentration or total NOz"'N03 (NO (x)) fn the test samples was determined by the modtfltatlon of the procedure described by Bnman and Hendrix [12] usfn1 the purse system of a Stew:rs .,struments model 2108 Httrlc Oxide Analyzer (NOA, Sfellers .,struments Inc). Briefty, the urine samples were diluted 10 times ti distilled water before anal~fs. A saturated solution of VCl3 In 1 mol/L HCI was prep.-ed 111d filtered before use. A tatal of 5 ml of the reqent was added to the purp wssel 111d pufled with nttraeen ps for 5 to 10 nmutes before use. The purp 11eSSel WllS equipped with a cold"Wllter condenser and a water jacket to permtt heaUn11 of the reqent to 95 (degree sllln) Celsfus, ust'l1 a drculattia water bath. The hydroc:hlortc: acid vapors were removed by a ps bubbler contaln '11 [nearly=] 15mlof1 mol/L NaOH. The gas flow rate fnto the chemolumlnescence detector was controlled usfng a needle valve adjusted to yteld a cell pressure of [nearly •) 7 mm Hg. The flow rate ot nltroten Into the purse vessel was ad"stecl to prewnt vacuum dfstllattcri of the reapnt.
Simples were fnjected fnto the purte wssel to react with the VC13/Ha reqent, whfch CCll'IW:rted nitrite, n1trate, and S-nltraso ccrnpounds to NO. The HO product was st,..,ped from the reaction chamber (by puf1'111 with nltf08en and vacuum) and detected by mane-Induced chemllumfnescence fn the chemiluminescence detector.
The slllnlll aenerated (NO pellk and pellk 11rea) was recorded and processed by a Hewlett-Padwd model 3390 lntevatar. In a typical assay, 5 micro Liter or the test sample was tljected to the purge vessel, and all samples were run fn t,..,lftate. Plasma samples were deprotelnlzed with cdd ethanol and Injected •the urine samples lbove.
A standard cumi was constructed usln& YllriDus concentntlons d N03° (5 to 100 micro mcl/L) relalfn& the lum'1escence produced to the pen No,; cmicentmlons d the stlllldard solutfcns. The amount of NC>it In the test sample WllS determ'1ed by fnterpcllltbl d the result tlto the standard cumi.
Determination of cGMP, ET·1, and ET·3 ET'·1 Sid ET'·l fn extracted plasma and urfne were measured by redlotmmunoassay kits purchased fRlm Pentlsula Laboratories. c:GMP t1 plasma and ur1ne we also measured with an radlommunoassay kit supplted by Hew Er11land Nuclear.
Determination of Lfpoperoxtdes in Pluma and Kidney Cortex ~ralddes t1 plasma were detenft'led by hllh·pemrmance llQuld ctiromlt011'1PhY measurement of MOA·TBA acccirdln1 the method ofWon1- [13] [14] The whClle procedure, briefly, is as follONS: A volume ol 50 micro Liter plasma WIS milaed with .75 mL 0.44 M H 1 PO.., 0.25 mL aqueous 42 mmcl/L TBA, and 0."5 ml H 2 0. The mixture was heated In a bcllln1 water bath fir 60 mfnutes. After coolti1 m tee, an equal volume of alkalt'le meth111cl (50 ml meth1nol + 4.5 ml 1 N NIOHJ was added. A volume of 50 micro Uter of tile neutralized reaction mixture WIS tllen injected tlto a 4.6 x 250-mm chromatc1raphlc cd.umn packed with micro Bondapak C18 (5-mtcro meter particle diameter). A guard cclumn, 3.9 x 23 mm, pacbd with Bonda,M Cautl C18 (37· to ~micro meter pllrtlcle dfmneter) was used. Mmle phase was a mixture of SO mmcl/l phosphate buffer (pH 6.8; 600 ml) and methll'lol (o400 ml). The ftow was 1 ml/m'1, and detection was dme at 532 nm. The concentration of plasma Upaperaicldes was determ'1ed trun the callbratlCll'I curw prepared with a tetnmethCKYPropane standard solutb'I (.61 to 4.86 micro mcl/l), processed exactly as the plasma semples.
~ralddes t1 kidney cortex were measured by h11ti't>erlonnance liquid chn:matography meeurement of the MDA·TBA accordln1 to the metllod of Draper et al.
[15] The tilsue samples were mi'lced, and duplicate 0.5~ snples were placed i'I 15 x 1~mm pyrex tubes. A total ol 5 mL of 10X trichloracetic acid plus o.25 ml of !ilOO ppm BHT fn methancl were added. After heatfn1 in a bolling water bath for 30 minutes, the sample WIS collected and centrlfuted at 2!il00 rpm for 
Plasma Concentration and U11nary Excrvtion of NOx and cGMP
There were no sipificant differences in plasma NOx lewls when lead-treated rats were compared with CCll'ltrol rats. In lead-treated rats, the plasma concentration of ET'·3 was Tlcreased ~nificantly abow: that al the CCll'ltrol. rats (Table 2) , but there was no change in plama concent111tian of ET'·1. Urinary excretion of ET'·l ti lead-treated ms was Ibo stptliCllntly hlllher th111 that of control rats, but tllere was no change ti umary eiccretian of ET'·1 ( Discussion ~ure to low but not "WI lewis of lead has been reported to cause hypertensb'I fn hum1ns and antnels. [1-61 NI fncrease fn blood pressure of rats oc:airs at lciw lead e.Jq*ure lewis of appraiclmately 0.1 to 100 ppm, which is siTlilar to the e.Jq*ure lewis seen in the envll'Cll'lment. ~r. rats eJcpased to ca1centrattons greater than 500 ppm of lead (equlwllent to lndustrllll lewl opasure) do nat develop hypertension. Our previous studies suaeste<I that the elevation in blood pressure was related to an increase in ... endothellal~er1vecl vmoconstrtctor (ET'·l) associated with decreased cyclic GMP as a second messenger for the vasodllator canpound, EDRF, and that 1nother vasoconstrtctor, the Na, K, AT'Pase lnhlb1tor·ca1ta1nln1 hypertenstan-8SSOdated protetl, was also tlcreased with low lead feedfn1. (A recent report 1211
showed that 1nht>ttlon of Na, K, ATPase by oulblfn causes lmpSlllent of ace~cholt'le-fnduced relantlon tl human resistance arteries, conststent with an eft'ect on EllRF synthesis or release and therefcre affording a passible link between these two effects.) we shcMed also that ION lead feedfng increased rather than decreased glomeruler flltnltlon rate end that no morphcloglcel or renal funct1cllal abnormalities -re associated. [22] In the study presented here, blood lead concentratiCllls at 3 months ti lead-treated rats l').01S lead acetate 1n drlnldn9 water) -re much hlllher than those In contrcl rats but lOllll"er than thclff in low lead·treated rats studied previously (12.4 +/· U wrsus 29.4 +/· 4.1 micro 1rem/dL). The epparent reason for the difference was that a stendard chaw was used In place of the S)Tlthettc dt.t used previously. The latter ts known to tlcrease susceptlb111ty to lead tmclclty, possl>ly through a le7ft1er calcium content (4n of labcntcty chow). (23) Despite the lower blood lead lew:ls, an elevation of blood pressure produced by ...-ure to lead was ccnfinned by the present lnvestlptbl.
There W11S a slpfflcant tlcrease In plasma concentration and In ur1nary ellCretbl d ET·3 but no chlll'lge ti plmma ccncentratfon or ur1nary eiacret1cl1 d ET·1. The plasma results -re compatt>le with the results of the prior study, [5] although the absolute values for plasma concentrations af ET ·l and ET· 1 -re lclwer because of the use of extracted rather th1n unextrected plasma. It was notev.athy that ur1nary lewis of ET'·l were also elevated, tlasmuch as sewral studtes have shown that ur1nary endotheltl ts a better reftectlon of lntrarenal events.
[2+26] 18 lead deposition ts localtzed prlmal1ly to the practnal tubule rA the ktdney [27] 1nd as ET ·l ts produced within thts seF1ent of the nephron, (2B] this suggests that the effect al lead on enclothel In production may occur via Inc re med renal tubular rather than '<lllKUlar endotheltl synthesis. Althoullh ET-3 ts a leD potent vasoccnstrlctor than ET-1, (29·31] It appears to be a contributory factor to the hypertension Induced by lead.
EDRF was also thoullht to play a alttclll role In lead·tlduced hypertension In our e11rller study, as bath plasma and urinary lewls al cGMP, the second messen9er for EllRF, -re reduced by lead adnmtstratlon. 1.5] In the present experiment, by contrast, EDRF, as measured by plasma and urine cGMP and more directly by NO, was unatrected by lead. Howewir, HO lew:ls reflect the bal1nce between HO synthesis Via NOS •d NO dearadatton, a process affected by e.icposure to ROS. (32, 33] Levels of clrculatcty NO may be increased, normal, ot decreased when l'<IOS actlYity and ROS are simultaneously increased, as eiaempltfled by studies of eJcperfmental cclttis fn rats, 1.341 In whtch tissue NO and 1105 levels were enhanced by cytolmes despite a concomitant decrease ti superadde dtsmutase (and thus lll1 lnaease In the ROS superaidcle anion).
Measurement d NOS activity fn brain wes bind to be Increased after lead eicpc11Ure, whereas In kidney cortex INOS, but not ecNOS, pnitetl mass was Increased, 1ncltcatt11 that HO synthesis was uprepleted. Of Interest ts the 1n Vitro observation that lead fnhtllts rather than stimulates bra. constltuttw NOS activity [35,361 while hlllint no effect on cytdme-i'lducl>le brain NOS actiYity, [36] therefore nplyint that 9' 1 the present study the increased NOS activity is a compensatory response to NO degradlltlan by ROS or seccndary to 11nother biochemical chanp Induced by lead oposure. An tlcreased production of ROS In response to lead, previously suggested by Hennes-Lima et al, [37] was confirmed by the elewted lewis of MDA·TBA '1 plasma 11nd kidney cortex of lead-treated rats.
A further Implication al the results ts that under the d'cumstances of the present study, Increased ROS, rather than decreased EDRF, may be -af the pr1ndpal reasons for lead·fnduced hypertension. First, -haw shown that the ROS scawngers 2 There ts mo prelfmtlary eYldence that another ROS, the hydrrayt r.:llcel, m~ be more patent than superaxlde ll'ltorl In eliciting vmcular contractions. Auch·Schwelk et al [42] demCll'lstrated that aortic rfnp from spCll'ltaneously hypertenstve rats had CCll'lcentratton-dependent Clll'ltractfons on e>cpolUre to xantht'le plus xanthtie«ldase· del'Mlcl ROS. Althoulh superadcle dismut•e and c:atal•e (the enzyme that de9rades hydrqien peraicide) shQMed modest effects in reducins the contractile tensiDn, defen11111111fne, the Iran chellltcr that prewnts the generlltlan of hydrmcyl radlclll from hydrogen peradde, totally aballshed the cont111Ct1ons. Dreher and Junxl [43] also demCll'lstratecl that hypCllClllthtle·xanthh! Gllddase exposure led to an '1crease '1 fntrac:ellular cal.cfum ti human umbilical vetl endothelial cells, lf'ld thts '1crease was inhibited by o-phenanthrd.i'le, a ccmpound that blocks the iren-catalyzed fu'maticn of hydmcyl radical.
In summary, lcw lead admfntstratfon Increases blood pressure via an tlcrease ti the vasoc:onstr1c1t11 compounds ET ·3 and ROS. EDRF lewils were unaffec:ted ti the present study as increased s~thesis and delJ'ldation were balanced.
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